| 产品名称: | Monoclonal Anti-Human Interferon Beta Protein, Clone A7 (produced in vitro) |
|---|---|
| 商品货号: | TS185902 |
| Agent: | Monoclonal Anti-Human Interferon Beta Protein, Clone A7 (produced in vitro) |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | frozen |
| Storage Conditions: | -20°C or colder. Repeated freeze-thaw cycles should be avoided. |
| Comments: | Antibody Class: IgG2ak The B cell hybridoma was generated by the fusion of P3X63Ag8.653 myeloma cells with splenocytes from a BALB/c x DBA F1 mouse immunized repeatedly with recombinant human IFN-β protein in adjuvant. The clone A7 antibody is specific for human IFN-β and does not cross-react with IFN-α or IFN-γ. |
| Name of Depositor: | SE Grossberg, Medical College of Wisconsin |
| Source: | Mouse monoclonal antibody prepared against a recombinant form of the human interferon beta protein was purified from clone A7 hybridoma supernatant by protein G affinity chromatography. |
| References: | Redlich PN, SE Grossberg. Analysis of antigenic domains on natural and recombinant human IFN-β by the inhibition of biologic activities with monoclonal antibodies. J. Immunol. 143: 1887-1893, 1989. PubMed: 2476486 Runkel L, et al. Mapping of IFN-β epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis. J. Interferon Cytokine Res. 21: 931-941, 2001. PubMed: 11747625 |